These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15998416

  • 1. Use of mycophenolate in the treatment of autoimmune hepatitis.
    Oo YH, Neuberger J.
    Liver Int; 2005 Aug; 25(4):687-91. PubMed ID: 15998416
    [No Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.
    Czaja AJ.
    J Hepatol; 2009 Jul; 51(1):8-10. PubMed ID: 19446910
    [No Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil--a new treatment for autoimmune hepatitis?
    Dhawan A, Mieli-Vergani G.
    J Hepatol; 2000 Sep; 33(3):480-1. PubMed ID: 11020006
    [No Abstract] [Full Text] [Related]

  • 4. [Auto-immune hepatitis: therapeutic management].
    Pariente A.
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B13-9. PubMed ID: 12843932
    [No Abstract] [Full Text] [Related]

  • 5. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
    Brunt EM, Di Bisceglie AM.
    Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
    [Abstract] [Full Text] [Related]

  • 6. Role of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Schramm C, Lohse AW.
    J Hepatol; 2011 Sep; 55(3):510-511. PubMed ID: 21281682
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, Lilly LB, Heathcote EJ, Deschenes M, Lee SS, Steinbrecher UP, Yoshida EM.
    Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
    Adams B, Lazarchick J, Medina AM, Willner IR, Neville B, Murphy E, Stuart R, Costa LJ.
    Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug choices in autoimmune hepatitis: part B--Nonsteroids.
    Czaja AJ.
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes.
    García-Buey L, Moreno-Otero R.
    Aliment Pharmacol Ther; 2011 Sep; 34(6):682-4; author reply 684-5. PubMed ID: 21851370
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.